
USA - NASDAQ:VLRX -
The current stock price of VLRX is 0.2568 null. In the past month the price decreased by -67.31%. In the past year, price decreased by -97.08%.
Valeritas Holdings Inc. is a commercial-stage medical technology company which focused on developing technologies for Type 2 diabetes. The company's product pipeline consists of V-Go (R) Disposable Insulin Delivery device, is a simple, wearable, basal-bolus insulin delivery solution for Type 2 diabetes which enables patients to administer a continuous preset basal rate infusion of insulin. Valeritas Holdings Inc. is headquartered in Bridgewater, New Jersey.
Valeritas Holdings Inc
750 ROUTE 202 SOUTH SUITE 600
BRIDGEWATER NJ 08807
CEO: John E. Timberlake
Phone: 908-927-9920
Valeritas Holdings Inc. is a commercial-stage medical technology company which focused on developing technologies for Type 2 diabetes. The company's product pipeline consists of V-Go (R) Disposable Insulin Delivery device, is a simple, wearable, basal-bolus insulin delivery solution for Type 2 diabetes which enables patients to administer a continuous preset basal rate infusion of insulin. Valeritas Holdings Inc. is headquartered in Bridgewater, New Jersey.
The current stock price of VLRX is 0.2568 null. The price decreased by -9.32% in the last trading session.
VLRX does not pay a dividend.
VLRX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on VLRX.
ChartMill assigns a fundamental rating of 3 / 10 to VLRX. Both the profitability and financial health of VLRX have multiple concerns.
Over the last trailing twelve months VLRX reported a non-GAAP Earnings per Share(EPS) of -11.64. The EPS decreased by -115.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -183.82% | ||
| ROA | -109.3% | ||
| ROE | N/A | ||
| Debt/Equity | 1.74 |